CERVIVA research on molecular markers for cervical screening was recently presented by Dr Cara Martin at the Institute of Biomedical Science.
CERVIVA presents research findings at Institute of Biomedical Science
15 Mar 2022
Professor John O'Leary wins TCD Provost's Innovation Award
22 Feb 2022
Congratulations to Prof John O’Leary, Chair of Pathology at TCD, Consultant Pathologist at St James Hospital and Director of Pathology at the The Coombe Women & Infants University Hospital on winning The Provost’s Innovation Award at TCD.
All of us here at CERVIVA feel so privileged and proud to have such an inspirational leader driving innovation.
Trust and cancer screening: Effects of a screening controversy on women’s perceptions of cervical cancer screening
02 Jan 2022
A new paper published by researchers from CERVIVA concludes that women’s perceptions of, and trust in, cervical screening have been adversely affected by the recent screening controversy. The findings can be used to inform the development of strategies to address women’s concerns and start to rebuild trust in screening.